Sequoia Financial Advisors, LLC - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLP and the CUSIP is 81369Y308. A total of 847 filers reported holding SELECT SECTOR SPDR TR in Q1 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
Sequoia Financial Advisors, LLC ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$939,454
-11.3%
13,653
-4.4%
0.02%
-11.1%
Q2 2023$1,059,564
-3.4%
14,286
-2.7%
0.02%
-25.0%
Q1 2023$1,096,873
+9.2%
14,682
+9.0%
0.02%
-4.0%
Q4 2022$1,004,293
+81.9%
13,471
+62.9%
0.02%
+47.1%
Q3 2022$552,000
-46.0%
8,272
-41.6%
0.02%
-41.4%
Q2 2022$1,022,000
+6.0%
14,154
+11.4%
0.03%
+20.8%
Q1 2022$964,000
+17.8%
12,701
+19.7%
0.02%
+9.1%
Q4 2021$818,000
+213.4%
10,609
+179.9%
0.02%
-18.5%
Q3 2021$261,000
-57.8%
3,790
-57.2%
0.03%
+17.4%
Q2 2021$619,000
-4.0%
8,846
-6.2%
0.02%
-14.8%
Q1 2021$645,000
+1.4%
9,4350.0%0.03%
-6.9%
Q4 2020$636,000
+3.9%
9,435
-1.2%
0.03%
-9.4%
Q3 2020$612,000
+10.7%
9,551
+1.2%
0.03%
-3.0%
Q2 2020$553,000
+111.1%
9,435
+96.4%
0.03%
+73.7%
Q1 2020$262,000
-13.5%
4,8050.0%0.02%0.0%
Q4 2019$303,000
+2.7%
4,8050.0%0.02%
-9.5%
Q3 2019$295,000
+8.5%
4,805
-10.2%
0.02%
-32.3%
Q4 2018$272,000
-5.9%
5,3500.0%0.03%
+6.9%
Q3 2018$289,000
-22.1%
5,350
-17.9%
0.03%
-25.6%
Q4 2017$371,000
+7.8%
6,520
+4.1%
0.04%
-9.3%
Q2 2017$344,0006,2610.04%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q1 2021
NameSharesValueWeighting ↓
Sage Financial Management Group, Inc. 6,785$467,00011.71%
J.Safra Asset Management Corp 476,263$32,785,0007.94%
Strategic Value Partners, LLC 720,000$49,565,0006.87%
Beaumont Capital Management, LLC 113,347$7,802,0006.69%
AGF Investments LLC 912,395$62,809,0006.20%
Conservest Capital Advisors, Inc. 686,225$47,240,0005.32%
Bellwether Advisors, LLC 214,597$14,772,0004.92%
Chicago Wealth Management, Inc. 90,823$6,252,0004.56%
Rothschild Capital Partners, LLC 201,575$13,876,0004.43%
Capital Advantage, Inc. 220,570$15,184,0004.10%
View complete list of SELECT SECTOR SPDR TR shareholders